How prostate cancer becomes diagnosis resistant

Amadeo01 Mar, 2019Health

Now, scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified how prostate cancer transforms into assertive NEPC following diagnosis with anti-androgen therapy. Their commentary � that embody a metabolic rewiring and a epigenetic alteration that drives this switch � exhibit that an FDA-approved drug binds intensity as a NEPC treatment. The investigate also uncovers new healing avenues that could forestall this mutation from occurring. The investigate was published in Cancer Cell.